Ecor1 Capital LLC is a San Francisco-based investment firm that focuses on identifying and supporting innovative therapeutics in the biosciences industry, with the aim of improving patient lives. They are known for their holistic evaluation approach and targeted search for groundbreaking solutions that have the potential to transform medical outcomes.
Driven by a patient-centric ethos, Ecor1 Capital invests in companies that demonstrate the greatest potential to make a positive impact on patient well-being. With a unique blend of scientific and strategic expertise, they engage as thought partners with their portfolio companies, fostering a true symbiotic relationship. By vetting for exceptional management, strong science, and rational financing strategies, Ecor1 Capital aims to forge the future of biotech and contribute to the development of promising new treatments for untreated diseases.
Generated from the website